Skip to main content
Clinical Trials/CTRI/2019/02/017756
CTRI/2019/02/017756Completed未知

Comparison of Nalbuphine and MgSO4 as an adjuvant to 0.5% Hyperbaric Levobupivacaine in subarachnoid blockade for lower limb surgeries.

IMS BH0 sites135 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
135

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • ASA Grade 1, 2
  • Patients scheduled to have various lower limb sugeries.

Exclusion Criteria

  • Patient who refuse to participate in study.
  • Patients not opting for subarachnoid block as anaesthetic technique.
  • Patients with local infection or significant coagulopathy.
  • Patients with severe cardiopulmonary disease.
  • Patients with blood volume deficit.
  • Patients with allergy to local anaesthetics or study drugs.
  • Patients with long term opioid use.
  • Patients with Peripheral Neuropathies,scoliosis.

Investigators

Sponsor
IMS BH

Similar Trials